TWP
SLS icon

Tyche Wealth Partners’s SELLAS Life Sciences SLS Stock Holding History

Tyche Wealth Partners’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-37,500
Closed -$141K – 363
2025
Q4 		$141K Hold
37,500
– – 0.02% 325
2025
Q3 		$60.4K Buy
+37,500
New +$66.8K 0.01% 312

Other funds holding SLS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $250B AUM 21.32% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Tyche Wealth Partners's SLS Position: Q1 2026 in Review

Tyche Wealth Partners sold out of SELLAS Life Sciences (SLS) in Q1 2026, closing a stake of 37,500 shares — an estimated $141K sold.

Tyche Wealth Partners first reported a position in SLS in Q3 2025 and held it in 2 quarters. The position peaked at $141K in Q4 2025. 160 funds tracked by Wall St. Rank hold SLS as of Q1 2026.

  • Tyche Wealth Partners reported no remaining SELLAS Life Sciences position as of Q1 2026 after selling out during the quarter.
  • Tyche Wealth Partners sold 37,500 SELLAS Life Sciences shares in Q1 2026, an estimated $141K.
  • Tyche Wealth Partners first reported a position in SELLAS Life Sciences in Q3 2025 and held it in 2 quarters.
  • Tyche Wealth Partners's SELLAS Life Sciences position peaked at $141K in Q4 2025.
  • 160 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q1 2026.

Based on Tyche Wealth Partners's 13F filing for Q1 2026, filed 6 May 2026.